69849-34-9 Usage
Uses
Used in Pharmaceutical Industry:
5-Bromo-4-Methylpyrimidin-2-ol is used as an active pharmaceutical ingredient for its enzyme-inhibiting properties, which can be leveraged in the development of new drugs targeting specific biological pathways. Its unique chemical structure allows for the modulation of enzyme activity, making it a promising candidate for treating various diseases.
Used in Agrochemical Industry:
In the agrochemical sector, BMPO is utilized as a key component in the development of new agricultural products. Its enzyme-inhibiting capabilities can be applied to control pests and diseases, thereby enhancing crop protection and yield.
Used in Organic Synthesis:
5-Bromo-4-Methylpyrimidin-2-ol is used as a reagent in organic synthesis for the creation of more complex molecules. Its bromine and methyl groups facilitate various chemical reactions, contributing to the synthesis of a wide range of organic compounds.
Used in Biochemistry Research:
As a tool in biochemistry research, BMPO aids in the investigation of biological processes and the development of new methodologies. Its unique structure and properties make it valuable for probing enzyme mechanisms and other biochemical interactions.
Overall, 5-Bromo-4-Methylpyrimidin-2-ol's diverse applications across different industries underscore its potential as a versatile chemical compound with significant implications for pharmaceutical development, agricultural advancements, and scientific research.
Check Digit Verification of cas no
The CAS Registry Mumber 69849-34-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,9,8,4 and 9 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 69849-34:
(7*6)+(6*9)+(5*8)+(4*4)+(3*9)+(2*3)+(1*4)=189
189 % 10 = 9
So 69849-34-9 is a valid CAS Registry Number.
69849-34-9Relevant academic research and scientific papers
5-Halopyrimid-2-ones
-
, (2008/06/13)
Novel derivatives of pyrimid-2-one having interesting pharmacological properties are described. The compounds of the invention have been found to be of use in the control of, and in particular in the inhibition of the metaphase of malignant tumours and le
